69097-369 : Docetaxel Anhydrous 20 mg/2ml Intravenous Injection, Solution
| NDC: | 69097-369 |
| Labeler: | Cipla USA Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Docetaxel Anhydrous |
| Dosage Form: | Intravenous Injection, Solution |
| Application #: | ANDA209634 |
| Rev. Date: |
NDC Package Codes:
- 69097-369-32: 1 VIAL, SINGLE‑USE IN 1 CARTON (69097‑369‑32) > 2 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Docetaxel Anhydrous
Dosage Strength:
- 20 mg/2mL
Pharmaceutical Classes:
- Microtubule Inhibition [PE]
- Microtubule Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 69097-371 Docetaxel Anhydrous 80 mg/8ml Intravenous Injection, Solution by Cipla USA Inc.
- 69097-372 Docetaxel Anhydrous 160 mg/16ml Intravenous Injection, Solution by Cipla USA Inc.
- 71288-144 Docetaxel Anhydrous 10 mg/ml Intravenous Injection, Solution by Meitheal Pharmaceuticals Inc
- 73358-210 Docetaxel Anhydrous 10 mg/ml Intravenous Injection by Curae Pharma360 Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 69097-368Next: 69097-371 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.